Quantitation of Free and Total Amphotericin B in Human Biologic Matrices by a Liquid Chromatography Tandem Mass Spectrometric Method
Authors:
- Jean W. LeeJLJean W. Lee
- Mary E. PetersenMPMary E. Petersen
- Patrick LinPLPatrick Lin
- Dawna DresslerDDDawna Dressler
- Ihor BekerskyIBIhor Bekersky
- 1 June 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 23 (3) , 268-276
Abstract
Amphotericin B remains the standard of care for the treatment of invasive and disseminated fungal infections. Various lipid-based formulations of amphotericin B have been developed to improve its therapeutic index by decreasing toxicity. Previous bioanalytic methods using microbial inhibition or high-pressure liquid chromatography quantified total amphotericin B (free, plasma protein-bound, and lipid-complexed). Sensitivity of this method with a low limit of quantitation of 0.05 μg/mL was inadequate to determine free (unbound) amphotericin B. A sensitive LC/MS/MS method was developed to determine the total amphotericin B value in human plasma and other biologic matrices and the free amphotericin B concentration in plasma. For determination of total plasma amphotericin B concentrations, the sample was diluted and injected onto the LC/MS/MS. For total amphotericin B in other matrices and free amphotericin B in plasma, solid-phase extraction was used. Natamycin served as an internal standard. A PE Sciex API 3000 (Sciex; Concord, Ontario, Canada) was used to assess free amphotericin B in plasma ultrafiltrate determination and an API 3+ for the other matrices, with electrospray interfaced to a C18 analytic column. The low limit of quantitation was 1 ng/mL for ultrafiltrate. For total amphotericin B, the low limits were 2 μg/mL for plasma, 0.05 μg/mL for urine, and 0.4 μg/mL for fecal homogenate. The methods were validated to show the standard range linearity, sensitivity, selectivity, accuracy, precision, and stability of amphotericin B in the matrices tested.Keywords
This publication has 23 references indexed in Scilit:
- Lipid-based amphotericin B formulations: from animals to manPharmaceutical Science & Technology Today, 1999
- Altered Tissue Distribution and Elimination of Amikacin Encapsulated in Unilamellar, Low-Clearance Liposomes (MiKasome®)Pharmaceutical Research, 1998
- AmBisome (Liposomal Amphotericin B): A Comparative ReviewThe Journal of Clinical Pharmacology, 1998
- Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogsAntimicrobial Agents and Chemotherapy, 1992
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standardAntimicrobial Agents and Chemotherapy, 1986
- Reproducible measurement of amphotericin B in serum by high-performance liquid chromatography in alkaline bufferJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Quantitative extraction of amphotericin B from serum and its determination by high-pressure liquid chromatographyAntimicrobial Agents and Chemotherapy, 1984
- An internally-standardized assay for amphotericin B in tissues and plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Quantitation of Amphotericin B with Use of High-Pressure Liquid ChromatographyThe Journal of Infectious Diseases, 1977